No Data
Innovative Medical Management: 2024 Interim Performance Forecast
AH trends diverge, Hang Seng Index up 0.6%, CNOOC up 4%, national bond futures slightly rebound.
Rare earth permanent magnets concept stocks pull back, photovoltaic and lithography themes also weaken. Hong Kong's real estate, banks, and oil & gas stocks are strong, CNOOC up 4%, Agricultural Bank of China and China Merchants Bank rise more than 2%. After experiencing a sharp drop yesterday, national bond futures rebounded in early trading, with 10-year and 30-year national bond futures contracts rising nearly 0.1% in early trading.
A-share noon review: Shanghai Composite Index fell 0.39%. Water conservancy and brain-computer interface concepts saw the largest increase, while the semiconductor sector adjusted.
As of the noon closing, the Shanghai Composite Index fell 0.39% below 3000 points, the Shenzhen Component Index fell 0.4%, and the Chinext Price Index fell 0.89%.
Shareholders Shanghai Ruixin and Shanghai Yanheng reduced their shareholding by 1% in Innovative Medical Management (002173.SZ).
Innovative Medical Management (002173.SZ) announced that on June 14, 2024, the company received investment from Shanghai Ruixin, Shanghai Yan...
Innovative Medical Management Co.,Ltd.'s (SZSE:002173) Popularity With Investors Under Threat As Stock Sinks 27%
Jinjiang Electronics' IPO review status on the Shanghai Stock Exchange has changed to "terminated." It is an innovative enterprise in the field of cardiac electrophysiology.
According to the news from the Zhitong Financial APP, on June 5th, Sichuan Jinjiang Electronic Medical Equipment Technology Co., Ltd. (referred to as Jinjiang Electronics) had its IPO review status changed to "terminated" by the Shanghai Stock Exchange. The Shanghai Stock Exchange terminated its IPO review because Sichuan Jinjiang Electronic Medical Equipment Technology Co., Ltd. and its underwriter withdrew their application for listing and issuance, in accordance with relevant provisions of Article 63 of the "Stock Issuance and Listing Review Rules" of the Shanghai Stock Exchange. According to the prospectus, the company focuses on research, development, production and sales of high-end innovative medical equipment for heart electrophysiology diagnosis and ablation, whose core products' quality and performance are benchmarked against international leading products.
More Unpleasant Surprises Could Be In Store For Shenzhen Sea Star Technology Co., Ltd.'s (SZSE:002137) Shares After Tumbling 27%No Data
